Publication Detail
Citation : |
Horton JS, Buckley CL, Stokes AJ. (2013)
Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.
Channels (Austin) 7(1):17-22.
|
Abstract : |
Heart failure is becoming a global epidemic. It exerts a staggering toll on quality of life, and substantial medical and economic impact. In a pre-clinical model of cardiac hypertrophy and heart failure, we were able to overcome loss of heart function by administering the TRPV1 antagonist BCTC (4-(3-Chloro-2-pyridinyl)-N-[4-(1,1-dimethylethyl)phenyl]-1-piperazinecarboxamide). The results presented here identify TRPV1 antagonists as new treatment options for cardiac hypertrophy and heart failure.
|
URL Link : |
http://www.ncbi.nlm.nih.gov/pubmed/23221478
|
PMID : |
23221478
|
PMCID : |
PMC3589277
|
|
|
Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.